Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
Saved in:
| Main Authors: | Magdy Mohamed Allam, Ramy Mohamed Ghazy, Hanaa Tarek Hussein Elzawawy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1473224/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyroid peroxidase antibodies and their role in predicting outcomes in Graves’ disease treatment
by: Klara Gewert, et al.
Published: (2025-04-01) -
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01) -
Evaluation of Clinical Characteristics and Treatment Outcomes of Graves Disease in Children and Adolescents
by: Alev Aldemir Sönmez, et al.
Published: (2021-03-01) -
Updates in the Management of Graves Disease in
Children
by: Yun Jeong Lee
Published: (2023-12-01) -
A Rare Case Of Acute Pancreatitis Cause by Newly Diagnosed Graves’ Disease: A Successful Therapeutic Option
by: Azzaki Abubakar, et al.
Published: (2025-08-01)